PubMed دسترسی آزاد

Sustainability of infectious disease elimination: a scoping review on integrating treatment and surveillance within health systems.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

BACKGROUND: Global infectious disease elimination programmes have historically relied on vertical, donor-driven approaches. However, amid reduced global funding and increased emphasis on country ownership and sustainability, interest in infectious disease-specific activities integrated into routine health systems is growing. Yet evidence on how integration has been implemented remains fragmented. This scoping review takes a multi-disease approach to assess the extent and nature of evidence on the integration of infectious disease elimination and eradication programmes into routine health systems, with a focus on treatment and surveillance functions. The review was conducted following Joanna Briggs Institute guidelines and using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews framework. OBJECTIVES: The objectives were to map and synthesise integration approaches, identify context-specific facilitators and barriers and review research methods used. ELIGIBILITY CRITERIA: Eligible studies were peer-reviewed, examined efforts to integrate treatment and/or surveillance functions for diseases with elimination or eradication goals into health systems, and reported at least one outcome. Articles were published between 2010 and 2024 on studies conducted in low- and middle-income countries. SOURCES OF EVIDENCE: MEDLINE, Embase, Global Health and Web of Science were searched. CHARTING METHODS: Data were charted using a standardised extraction form that captured study characteristics, integration activities, health system level, facilitators and barriers, outcomes measured and research methods. Extracted data were synthesised descriptively using quantitative summaries and qualitative thematic analysis to identify patterns across studies. RESULTS: The search yielded 5938 records, of which 45 studies met inclusion criteria. Studies spanned 23 countries and 20 diseases. Integration commonly involved task shifting to primary healthcare providers, expanded roles for community health workers and new responsibilities for district and national health authorities. Key facilitators included adopting a health systems strengthening approach with strong government ownership. Barriers included supply chain challenges, unclear roles and weak partner coordination. Evidence on costs was limited, though some studies described initial donor-funded start-up with longer-term absorption by governments. The study designs reflected varied disciplinary perspectives. CONCLUSIONS: This review identifies substantial gaps in the evidence base on implementing integration, particularly regarding surveillance and the economic implications of integration. However, common principles emerged across diverse settings and diseases that can inform future integration efforts. Across the included studies, integration was consistently described as a health system change process, with implications for research, policy and practice related to early planning, stronger country leadership and donor coordination, broader engagement across the health system and health system strengthening.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

Health ServicesHealth policyINFECTIOUS DISEASESInfection controlNeglected DiseasesPrimary Health Care
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and enviro…

PubMed2026

Global, Regional and National Burden of Viral Hepatitis From 1990 to 2021 With Forecasts to 2046: Findings From the Global Burden of Disease Study 2021.

Viral hepatitis constitutes a primary cause of liver cirrhosis and carcinoma and ranks as the second leading cause of mortality worldwide due to challenges in early detection and limited preventive measures, thereby posing a significant threat to public health. This study analyses the burden and risk factors associated with viral hepatitis at global, regional, and national levels from 1990 to 2021, and projects the disease burden from …

PubMed2026

Temporal trend analysis of the global prevalence of vision impairment and blindness attributable to diabetes from 1990 to 2021.

BACKGROUND: This study aimed to systematically assess the burden and temporal patterns of vision impairment due to diabetes mellitus (DM), including moderate vision loss (MVL), severe vision loss (SVL), and blindness, and to identify the demographic drivers of future changes. METHODS: An age-period-cohort (APC) model was used to evaluate the effects of age, period, and birth cohort on diabetes-related vision impairment, with analyses s…

PubMed2026

Antimicrobial resistance and social inequity: Why the one health approach must centre poverty.

Antimicrobial resistance (AMR) is one of the most consequential threats to global public health. In 2021, bacterial AMR was associated with an estimated 4.71 million deaths globally, including 1.14 million directly attributable to resistance. Yet, despite its designation as a global emergency, policy responses remain heavily focused on surveillance, antimicrobial stewardship, diagnostics, and pharmaceutical innovation. These interventi…